Cardiomyopathy Flashcards
epidemiology of cardiomyopathies
accounts for 5-10% of heart failure of the 5-6 million pts with this diagnosis in the US
etiology of cardiomyopathy
- primary intrinsic - d/t myocardial dz - genetic disorders of myocardial fibers
- secondary intrinsic cardiomyopathy d/t systemic dz or to another cause - sarcoidosis, hemochromatosis, chronic anemia
3 main patterns of cardiomyopathies
- dilated
- hypertrophied
- restrictive
s/s of cardiomyopathies
- DOE d/t increased LV/LA/PA pressure
- fatigue - decreased CO
** with advancing dz there is progressive DOE with mild activity, orthopnea and PND
definition of dilated cardiomyopathy
most common 90% of cases
-an enlarged LV (dilation with contractile dysfunction) with decreased systolic function and ejection fraction (EF
epidemiology of dilated cardiomyopathy
causes 25% of all cases of heart failure
blacks more affected
men>women
age of onset 20-50yo
pathophys of dilated cadiomyophaty
impairment of ventricular contractility
- systolic failure is more pronounced than diastolic failure
- floppy or flabby thin and weak ventricles and atria
- enlarged - bw 2-3x the normal weight
- can sometimes see ventricular thickness (compensated heart failure)
causes of intrinsic dilated cardiomyopathy
genetic - 20-50% primary type
- idiopathic
- CAD as secondary cause
- Rx: alcohol, doxorubicin, adriamycin
- thyroid dz
- peripartum cardiomyopathy
- infections: coxsackie HIV lyme’s
- Chronic tachycardia
- sarcoidosis
- amyloidosis
- hemochromatosis
- diabetes
s/s of dilated cardiomyopathy
pulm rales elevated JVD cardiomegaly s3 gallop murmurs of mitral or tricuspid regurg (systolic) periperhal edema ascites
s/s in dilated cardiomyopathy in severe heart failure
- cheyne-stokes breaking - endstage LHF
- pulsus alternans - end stage LHF
- pallor
- cyanosis
diagnostic studies for dilated cardiomyopathy
- echo - confirms presence of dilated ventricle and reduced systolic function EF
treatment of dilated cardiomyopthy
- ACEi, ARBs, BB, diuretics, aldosterone antagonists - get rid of fluid
- sodium restriction
- anticoags d/t high risk of embolization
- digoxin as adjunctive tx
- tx underlying causes
definition of hypertrophic cardiomyopthy
obstructive vs non-obstructive
-increased LV hypertrophy w/o the presence of an underlying cause such as valvular dz (with an increase in pressure greadients) volume overload or systemic HTN
epidemiology of hypertrophic cardiomyopathy
- age of onset - any, but commonly seen in post puberty and young athletes (20-40)
- most common genetic cause of cardiac death in young people including trained athletes
main dysfunction in hypertrophic cardiomyopathy
increased diastolic filling pressure (diastolic failure or compliance impairment) from a stiff and small chambered hypertrophied LV